Spruce Biosciences Inc.

SPRB | NASDAQ

Price Alert Chart Builder DCF Calculator

$53.58

-$0.12 (-0.22%)

Sep 22, 2026, 12:10 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.22%

(1D)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $147.48M

1D Range

53.33 54.84

52W Range

7.26 240

Valuation (TTM)

PE -1.31

PB 1.77

EV/EBITDA -1.11

Valuation (NTM)

Forward PE 73.38

Forward PEG 0.01

Price Target $135.75

Cash Flow

FCF Yield -28.9%

SBC Adj. FCF Yield -31.4%

SBC Impact -8.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -132.1% | -9.4%

Dil EPS 3Y | 5Y 27.0% | 8.2%

FCF 3Y | 5Y 7.1% | -6.9%

Returns

ROA -49.9%

ROE -123.5%

ROIC -50.5%

Financial Health

Net Cash

$93.55M

Current Ratio 9.23

Interest Coverage -26.63

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Spruce Biosciences, Inc., founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatmen...

Sector Healthcare

Industry Biotechnology

Employees 22

IPO Date Oct 8, 2020

Website www.sprucebio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$144.50

Upside

+169.69%

Buy (5)

Hold (0)

Sell (0)

Analyst Details ➞